Persistent gene expression in mouse nasal epithelia following feline immunodeficiency virus-based vector gene transfer.
about
Current and Emerging Therapies for the Treatment of Cystic Fibrosis or Mitigation of Its SymptomsProgress and prospects: immune responses to viral vectorsCFTR delivery to 25% of surface epithelial cells restores normal rates of mucus transport to human cystic fibrosis airway epitheliumThe stability of human respiratory syncytial virus is enhanced by incorporation of the baculovirus GP64 protein.Restoring ciliary function to differentiated primary ciliary dyskinesia cells with a lentiviral vector.Use of the piggyBac transposon to create HIV-1 gag transgenic insect cell lines for continuous VLP production.Respiratory syncytial virus engineered to express the cystic fibrosis transmembrane conductance regulator corrects the bioelectric phenotype of human cystic fibrosis airway epithelium in vitro.Lysophosphatidylcholine as an adjuvant for lentiviral vector mediated gene transfer to airway epithelium: effect of acyl chain length.Genetic therapies for cystic fibrosis lung diseaseFerret and pig models of cystic fibrosis: prospects and promise for gene therapy.Abrogation of contaminating RNA activity in HIV-1 Gag VLPs.Development and Applications of VSV Vectors Based on Cell TropismAdvances in cell and gene-based therapies for cystic fibrosis lung diseaseTranscriptional targeting in the airway using novel gene regulatory elements.Development of lentiviral vectors with regulated respiratory epithelial expression in vivoLentiviral vector gene transfer to porcine airways.Intrapulmonary Versus Nasal Transduction of Murine Airways With GP64-pseudotyped Viral VectorsBaculovirus: an insect-derived vector for diverse gene transfer applicationsHuman, Pig, and Mouse Interferon-Induced Transmembrane Proteins Partially Restrict Pseudotyped Lentiviral Vectors.Lentivirus vector can be readministered to nasal epithelia without blocking immune responsesLentiviral-mediated phenotypic correction of cystic fibrosis pigs.Targeted gene delivery to the lung.High efficiency gene transfer to airways of mice using influenza hemagglutinin pseudotyped lentiviral vectors.Stem cell therapy for cystic fibrosis: current status and future prospects.Integrase-defective lentiviral-vector-based vaccine: a new vector for induction of T cell immunity.Lentiviral vectors and cystic fibrosis gene therapyA VSV-G Pseudotyped Last Generation Lentiviral Vector Mediates High Level and Persistent Gene Transfer in Models of Airway Epithelium In Vitro and In Vivo.rAAV-CFTRΔR Rescues the Cystic Fibrosis Phenotype in Human Intestinal Organoids and Cystic Fibrosis Mice.Acquisition of complement resistance through incorporation of CD55/decay-accelerating factor into viral particles bearing baculovirus GP64.Activation of transgene-specific T cells following lentivirus-mediated gene delivery to mouse lung.Identification of a GP64 subdomain involved in receptor binding by budded virions of the baculovirus Autographica californica multicapsid nucleopolyhedrovirus.Altering α-dystroglycan receptor affinity of LCMV pseudotyped lentivirus yields unique cell and tissue tropismAir-assisted intranasal instillation enhances adenoviral delivery to the olfactory epithelium and respiratory tract.Impact of lentiviral vector-mediated transduction on the tightness of a polarized model of airway epithelium and effect of cationic polymer polyethylenimineSynchrotron phase-contrast X-ray imaging reveals fluid dosing dynamics for gene transfer into mouse airways.Novel GP64 envelope variants for improved delivery to human airway epithelial cells.Lentivectors are efficient tools to manipulate the dendritic cell cytoskeleton.Gene therapy for Cystic Fibrosis: Improved delivery techniques and conditioning with lysophosphatidylcholine enhance lentiviral gene transfer in mouse lung airways.Lentiviral transduction of the murine lung provides efficient pseudotype and developmental stage-dependent cell-specific transgene expression.Olfactory loss and dysfunction in ciliopathies: Molecular mechanisms and potential therapies.
P2860
Q28077411-81489E39-45ED-4A4D-BF7C-1DDBD382C58FQ28264531-47DEA056-B08D-404C-9076-34534A0F6522Q28941756-4412D16C-6C0D-4496-B41F-60E7D3C6F4E9Q30440686-42AAE7CD-50C6-4F28-9257-62C8E37D3D1EQ30586012-0EFC298A-B540-4AF7-ACEB-A5A4B567DCF6Q33548128-8039C0A9-31C1-4018-81AA-B606D8A1DC36Q33964142-C064EEB8-D1B1-439C-AFBA-5820529A3720Q34000604-CAB330DC-8FD1-4BAC-85FA-AEF6749C1D6FQ34982862-29786737-8CAE-4094-9130-3F286839E1E0Q35200182-92514543-7040-408F-A58E-207D15EFBC03Q35478282-9393AB78-7405-41D1-832B-A7F0C2CFA2AAQ35679152-7CA85996-C1A5-4FA3-9A5A-8F23D50A3589Q36014033-C1214D1C-E0D0-4C33-A0FF-26949BD37D9BQ36176927-D7E8CFE0-56C5-4405-898E-B8757917CEB4Q36330666-5084CAEA-F07C-4370-A587-458813507592Q36438300-7B942939-D60D-4592-B043-042BCEED3735Q36587580-AA58908F-4FEB-42ED-9647-2372A6AF7086Q36740261-96DE12DF-EC63-481B-9640-946E489E21D1Q36825419-4D3D23DC-E589-4841-88F9-5A7200B40110Q36949698-57B12CFE-1E46-4E27-92BA-A8351A138FAFQ37265494-C680A47E-C977-4AD6-84A8-6C98FB35B169Q37486747-CACB7D45-6213-45B0-8BF4-3A6B1ED8D17DQ37633995-6DEC3A00-1B48-40E7-A16A-2AE55234A883Q37754873-293FC5E7-50C4-46F4-A6EE-50E1D392BAF9Q37857291-2D229E04-2B02-455A-B6F3-5AF8AFE1526BQ38614351-55E6D7E3-909B-4329-B467-965B1CA1EA4BQ38617943-D82F0852-FA6A-4DE3-B438-28A819A48218Q38949076-7560F04B-3439-49E8-B509-82DEF16406E6Q39609813-D9214251-D456-408B-A604-03B340706FA2Q39639271-7E3ADD26-C027-409D-ADEE-1D40DB23A322Q40011105-6F893F73-4C54-4384-B9C5-899D1D2694BDQ41980779-714ADE66-8D87-4A49-8FAA-D4C523B9CB29Q42076693-E37CC731-1CAA-4D8D-B9EA-189D18E1C3E0Q42738693-852DD4AC-1663-44AE-AF76-715B238147F4Q45870784-0070C6EC-6F1D-4509-AB8D-5FA264173CEEQ45871641-1BA69C04-AB54-42B4-9142-8024CF8F0214Q45871804-61401360-037D-4F1F-950D-1A78133B3286Q45875784-E8939D14-C6C1-49CF-A1D8-DA5B77C610CAQ45876976-6C224E33-3C7C-4EEF-A213-9BB4683BFEA7Q47557894-DA3B9B08-1D79-4F3F-8C59-336F738D7B8D
P2860
Persistent gene expression in mouse nasal epithelia following feline immunodeficiency virus-based vector gene transfer.
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Persistent gene expression in ...... us-based vector gene transfer.
@ast
Persistent gene expression in ...... us-based vector gene transfer.
@en
Persistent gene expression in ...... us-based vector gene transfer.
@nl
type
label
Persistent gene expression in ...... us-based vector gene transfer.
@ast
Persistent gene expression in ...... us-based vector gene transfer.
@en
Persistent gene expression in ...... us-based vector gene transfer.
@nl
prefLabel
Persistent gene expression in ...... us-based vector gene transfer.
@ast
Persistent gene expression in ...... us-based vector gene transfer.
@en
Persistent gene expression in ...... us-based vector gene transfer.
@nl
P2860
P50
P1433
P1476
Persistent gene expression in ...... us-based vector gene transfer.
@en
P2093
Erin R Burnight
Melissa A Hickey
P2860
P304
12818-12827
P356
10.1128/JVI.79.20.12818-12827.2005
P407
P577
2005-10-01T00:00:00Z